Skip to main content
Kabra Drugs Ltd logo

Kabra Drugs Ltd — Investor Relations & Filings

Ticker · 524322 ISIN · INE323K01017 BSE.NS Manufacturing
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 524322

About Kabra Drugs Ltd

https://www.kabradrugs.com

Kabra Drugs Ltd is an enterprise focused on the manufacturing, marketing, and distribution of a wide range of medicinal products. The company specializes in the production of bulk drugs, pharmaceutical intermediates, and finished formulations across various therapeutic categories. Its product portfolio includes generic medications, anti-infectives, and analgesics designed to meet diverse healthcare requirements. The organization emphasizes adherence to quality control standards and cost-efficient production processes to serve both wholesale and retail segments. It maintains a commitment to expanding its therapeutic reach through strategic product development and distribution networks, catering to healthcare providers and patients with essential solutions.

Recent filings

Filing Released Lang Actions
Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Board Meeting to be held on 29th May 2026
Regulatory Filings Classification · 79% confidence The document is an intimation under SEBI Listing Regulations of an upcoming Board Meeting to approve quarterly results. It does not present any financial figures itself nor announces a management change; rather it is a routine regulatory announcement. Therefore, it fits the ‘Regulatory Filings’ category as a general compliance notice.
2026-05-21 English
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the Annual Secretarial Compliance Report dated 15th May 2026, ....
Regulatory Filings Classification · 87% confidence The document is an Annual Secretarial Compliance Report pursuant to SEBI LODR Regulation 24A, prepared and certified by a Practicing Company Secretary and filed with BSE. It is an officer attestation/regulatory compliance certification rather than a full financial report, earnings release, or proxy material. Under the “Certification Rule,” such compliance certifications are classified as Regulatory Filings (RNS), serving as a fallback for miscellaneous regulatory submissions. The text encloses the report itself but is fundamentally a regulatory compliance filing rather than an Annual Report or Audit Report of financials.
2026-05-21 English
Intimation to stock exchanges regarding publication of postal ballot notice in newspapers.
Regulatory Filings Classification · 90% confidence The document is a stock-exchange disclosure dated May 12, 2026 from Kabra Drugs Limited under Regulation 30 of the Listing Regulations. It informs BSE Ltd of the publication of a Postal Ballot Notice in newspapers, enclosing copies of the advertisements. This is an event-driven compliance announcement rather than a report (e.g., financial, proxy statement) itself. No financial data or actual notice text is provided, and it serves as a regulatory intimation. Therefore it falls under the generic Regulatory Filings category (RNS).
2026-05-12 English
Postal Ballot Notice
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Kabra Drugs Limited, dated May 8, 2026. It references compliance with SEBI Listing Regulations and the Companies Act, 2013, and details the process for remote e-voting on special resolutions including a change of company name and alteration of the Memorandum of Association. The document includes procedural instructions, voting timelines, and appointment of a scrutinizer. It is a notice to shareholders to vote on corporate governance matters via postal ballot and electronic voting, not a report of voting results or a management report. It is not an Annual Report, Earnings Release, or any financial statement. It is also not a Proxy Solicitation or Voting Results announcement but a notice initiating the voting process. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2026-05-08 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.